Ensign Peak Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13M | Sell |
24,778
-18,898
| -43% | -$9.92M | 0.02% | 411 |
|
|
2025
Q1 | $27.7M | Buy |
43,676
+2,027
| +5% | +$1.29M | 0.05% | 255 |
|
|
2024
Q4 | $29.7M | Sell |
41,649
-1,093
| -3% | -$779K | 0.05% | 258 |
|
|
2024
Q3 | $44.9M | Sell |
42,742
-85,969
| -67% | -$90.4M | 0.08% | 201 |
|
|
2024
Q2 | $135M | Sell |
128,711
-4,471
| -3% | -$4.7M | 0.25% | 80 |
|
|
2024
Q1 | $128M | Sell |
133,182
-5,964
| -4% | -$5.74M | 0.23% | 88 |
|
|
2023
Q4 | $122M | Buy |
139,146
+11,490
| +9% | +$10.1M | 0.24% | 94 |
|
|
2023
Q3 | $105M | Buy |
127,656
+3,003
| +2% | +$2.47M | 0.22% | 96 |
|
|
2023
Q2 | $89.6M | Buy |
124,653
+76,094
| +157% | +$54.7M | 0.18% | 109 |
|
|
2023
Q1 | $39.9M | Sell |
48,559
-2,298
| -5% | -$1.89M | 0.09% | 198 |
|
|
2022
Q4 | $36.7M | Buy |
50,857
+228
| +0.5% | +$165K | 0.08% | 217 |
|
|
2022
Q3 | $34.9M | Sell |
50,629
-9,475
| -16% | -$6.53M | 0.09% | 201 |
|
|
2022
Q2 | $35.5M | Buy |
60,104
+14,405
| +32% | +$8.52M | 0.08% | 199 |
|
|
2022
Q1 | $31.9M | Sell |
45,699
-10,524
| -19% | -$7.35M | 0.06% | 228 |
|
|
2021
Q4 | $35.5M | Sell |
56,223
-33,665
| -37% | -$21.3M | 0.07% | 232 |
|
|
2021
Q3 | $54.4M | Sell |
89,888
-8,190
| -8% | -$4.96M | 0.11% | 165 |
|
|
2021
Q2 | $54.8M | Sell |
98,078
-4,258
| -4% | -$2.38M | 0.11% | 166 |
|
|
2021
Q1 | $48.4M | Sell |
102,336
-35,203
| -26% | -$16.7M | 0.1% | 170 |
|
|
2020
Q4 | $66.4M | Sell |
137,539
-13,692
| -9% | -$6.61M | 0.15% | 139 |
|
|
2020
Q3 | $84.7M | Sell |
151,231
-4,366
| -3% | -$2.44M | 0.21% | 93 |
|
|
2020
Q2 | $97M | Buy |
155,597
+70,382
| +83% | +$43.9M | 0.26% | 77 |
|
|
2020
Q1 | $41.6M | Buy |
85,215
+42,684
| +100% | +$20.8M | 0.14% | 119 |
|
|
2019
Q4 | $16M | Buy |
+42,531
| New | +$16M | 0.04% | 331 |
|